BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:40:00 PM | Browse: 464 | Download: 502
Publication Name World Journal of Gastroenterology
Manuscript ID 3923
Country of Manuscript Source Japan
Received
2013-06-02 17:52
Peer-Review Started
2013-06-03 13:47
To Make the First Decision
2013-07-19 08:23
Return for Revision
2013-07-21 16:20
Revised
2013-08-02 14:48
Second Decision
2013-08-08 19:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-08-09 01:17
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-08-15 17:43
Typeset the Manuscript
2013-09-16 16:27
Publish the Manuscript Online
2013-10-18 17:02
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Editorial
Article Title Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Toru Ishikawa
Funding Agency and Grant Number
Corresponding author Toru Ishikawa, MD, PhD, Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, 280-7 Teraji, Niigata 950-1104, Japan. toruishi@ngt.saiseikai.or.jp
Keywords Hepatocellular carcinoma; Intrahepatic distant recurrence; Multicentric recurrence; Hepatitis C virus; Interferon; Arterial chemotherapy
Core Tip Recent advances in treatment modalities have improved the survival rate of patients with hepatocellular carcinoma (HCC). However, long-term outcomes of patients with HCC remain unsatisfactory because of the high incidence of distant intrahepatic recurrence, multicentric recurrence and low survival rates. In particular, hepatitis C virus-related hepatocellular carcinoma has a much higher recurrence rate than other cancers. In this article, we describe the prognosis of recurrent HCC and the therapeutic strategies for reducing recurrent HCC.
Publish Date 2013-10-18 17:02
Citation Ishikawa T. Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma. World J Gastroenterol 2013; 19(37): 6127-6130
Url http://www.wjgnet.com/1007-9327/full/v19/i37/6127.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i37.6127
Full Article (PDF) WJG-19-6127.pdf
Manuscript File 3923-Review.doc
Answering Reviewers 3923-Answering reviewers.pdf
Copyright License Agreement 3923-Copyright Assignment.pdf
Non-Native Speakers of English Editing Certificate 3923-Language certificate.pdf
Peer-review Report 3923-Peer review(s).pdf
Scientific Editor Work List 3923-Scientific editor work list.doc